1-20 of 44
Jason Gotlib
Close
Sort by
Articles

Boy, Wonder: In Memoriam: Stanley L. Schrier, MD (1929-2019)

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2019) 16 (6)
https://doi.org/10.1182/hem.V16.6.9984
Published: 2019
Articles

Spur Cell Anemia

Sebastian Fernandez-Pol, MD, PhD, Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2019) 16 (5)
https://doi.org/10.1182/hem.V16.5.9783
Published: 2019
Articles

The Hematologist Welcomes Its Sixth Editor-in-Chief

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2017) 14 (6)
https://doi.org/10.1182/hem.V14.6.7900
Published: 2017
Articles

How We Mark Time and How Time Marks Us: A personal reflection on the 15-year journey leading to the approval of midostaurin for advanced systemic mastocytosis.

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2017) 14 (5)
https://doi.org/10.1182/hem.V14.5.7626
Published: 2017
Articles

A Joe Mikhael Icebreaker Fulfilled

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2017) 14 (3)
https://doi.org/10.1182/hem.V14.3.7351
Published: 2017
Articles

When More (Oxygen) Is Not Better

Scott Wendroth, MD, Evan T. Hall, MD, Mphil, Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7208
Published: 2017
Articles

Letter to the Editor: On the November December 2016 Image Challenge

John H. Baird, MD, Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.7022
Published: 2017
Articles

Hematology... Literally and Seriously

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.7018
Published: 2017
Articles

Blasts of a Different Sort

Jenny Hoffman, MD, John H. Baird, MD, Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.7021
Published: 2017
Articles

A Stimulating Case of Leukocytosis

John H. Baird, MD, Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2016) 13 (6)
https://doi.org/10.1182/hem.V13.6.6842
Published: 2016
Articles

ASH in Cuba: Unmasking Challenges and Opportunities in Hematology

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2016) 13 (4)
https://doi.org/10.1182/hem.V13.4.5672
Published: 2016
Articles

What We Carried on Christmas: Fiction for the Year's Best in Hematology

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2016) 13 (1)
https://doi.org/10.1182/hem.V13.1.4837
Published: 2016
Articles

Targeted Therapy in Lymphoproliferative Disorders (Excluding CAR T Cells)

Peter Johnson, MD, Jason Gotlib, MD, MS, Ann S. LaCasce, MD, MSc
Journal: The Hematologist
The Hematologist (2015) 12 (1)
https://doi.org/10.1182/hem.V12.1.3626
Published: 2015
Articles

Mutation of the Calreticulin (CALR) Gene in Myeloproliferative Neoplasms

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2015) 12 (1)
https://doi.org/10.1182/hem.V12.1.3546
Published: 2015
Articles

The Year's Best in Hematology 2014: Looking Backward, Moving Forward

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2015) 12 (1)
https://doi.org/10.1182/hem.V12.1.3547
Published: 2015
Articles

HIF and Hemoglobin in the Himalayas

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2014) 11 (6)
https://doi.org/10.1182/hem.V11.6.3387
Published: 2014
Articles

MLL3 is a Critical Tumor Suppressor in -7/del(7q) AML

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2014) 11 (5)
https://doi.org/10.1182/hem.V11.5.3189
Published: 2014
Articles

Validating Activated CSF3R Signaling as a Therapeutic Target in CNL and Atypical CML

Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2014) 11 (4)
https://doi.org/10.1182/hem.V11.4.3026
Published: 2014
Articles

Time to Retire the Old IMiD Mechanism of Action Slide

David Kurtz, MD, Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2014) 11 (3)
https://doi.org/10.1182/hem.V11.3.2741
Published: 2014
Articles

El Dorado Found: Calreticulin Mutations in JAK2 V617F-Negative MPN s

Mark P. Chao, MD, PhD, Jason Gotlib, MD, MS
Journal: The Hematologist
The Hematologist (2014) 11 (2)
https://doi.org/10.1182/hem.V11.2.2529
Published: 2014